Education
About Us
Working with TipRanks
Follow Us
Ceribell, Inc. (CBLL)
NASDAQ:CBLL
CBLL Stock Chart & Stats
$20.15
-$0.15(-0.64%)
At close: 4:00 PM EST
$20.15
-$0.15(-0.64%)
Day’s Range― - ―
52-Week Range$10.01 - $26.04
Previous CloseN/A
Volume46.56K
Average Volume (3M)367.64K
Market Cap
$717.43M
Enterprise Value$745.08M
Total Cash (Recent Filing)$168.54M
Total Debt (Recent Filing)$21.34M
Price to Earnings (P/E)―
Beta0.83
Next Earnings
Mar 03, 2026EPS Estimate
-0.41Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.37
Shares Outstanding37,095,690
10 Day Avg. Volume340,202
30 Day Avg. Volume367,638
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)1.62
Price to Sales (P/S)4.73
P/FCF Ratio-8.50
Enterprise Value/Market Cap1.04
Enterprise Value/Revenue9.00
Enterprise Value/Gross Profit10.22
Enterprise Value/Ebitda-15.17
Forecast
1Y Price Target
$29.67Price Target Upside47.25% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)-1.46
Revenue Forecast (FY)$112.67M
Bulls Say, Bears Say
Bulls Say
Commercial Adoption And Margin ResilienceStrong commercial traction, raised revenue guidance, an expanded sales force, and a new production line that reduces tariff exposure support scalable adoption and improved profitability.
Regulatory ExpansionFDA clearances for delirium plus neonatal and pediatric indications expand the addressable market and establish the system as the first US‑approved device for delirium screening and monitoring.
Technology Platform And Reimbursement PathwayA proprietary AI Clarity algorithm, breakthrough designation for large vessel occlusion stroke, and a submitted NTAP application position the platform to address multiple clinical indications and boost potential reimbursement.
Bears Say
Legal RiskOngoing patent litigation creates uncertainty that could delay regulatory outcomes and act as a legal overhang on the stock.
Ceribell, Inc. News
CBLL FAQ
What was Ceribell, Inc.’s price range in the past 12 months?
Ceribell, Inc. lowest stock price was $10.01 and its highest was $26.04 in the past 12 months.
What is Ceribell, Inc.’s market cap?
Ceribell, Inc.’s market cap is $717.43M.
When is Ceribell, Inc.’s upcoming earnings report date?
Ceribell, Inc.’s upcoming earnings report date is Mar 03, 2026 which is in 24 days.
How were Ceribell, Inc.’s earnings last quarter?
Ceribell, Inc. released its earnings results on Nov 04, 2025. The company reported -$0.37 earnings per share for the quarter, beating the consensus estimate of -$0.414 by $0.044.
Is Ceribell, Inc. overvalued?
According to Wall Street analysts Ceribell, Inc.’s price is currently Undervalued.
Does Ceribell, Inc. pay dividends?
Ceribell, Inc. does not currently pay dividends.
What is Ceribell, Inc.’s EPS estimate?
Ceribell, Inc.’s EPS estimate is -0.41.
How many shares outstanding does Ceribell, Inc. have?
Ceribell, Inc. has 37,095,690 shares outstanding.
What happened to Ceribell, Inc.’s price movement after its last earnings report?
Ceribell, Inc. reported an EPS of -$0.37 in its last earnings report, beating expectations of -$0.414. Following the earnings report the stock price went up 7.875%.
Which hedge fund is a major shareholder of Ceribell, Inc.?
Currently, no hedge funds are holding shares in CBLL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ceribell, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$29.67 (47.25% Upside)
$29.67 (47.25% Upside)
Blogger Sentiment
Bullish
CBLL Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 1.1M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.6%
Last 30 Days ▼ 6.2%
Last 30 Days ▼ 6.2%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-10.88%
12-Months-Change
Fundamentals
Return on Equity
-59.78%
Trailing 12-Months
Asset Growth
323.99%
Trailing 12-Months
Company Description
Ceribell, Inc.
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.
CBLL Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Ceribell demonstrated strong revenue growth and notable expansion in accounts, particularly within the VA system. However, increased operating expenses and net loss were significant concerns. The company is actively managing tariff impacts with supply chain adjustments.View all CBLL earnings summariesCBLL Stock 12 Month Forecast
Average Price Target
$29.67
▲(47.25% Upside)
Technical Analysis
Ownership Overview
16.46% Insiders
21.43% Mutual Funds
0.05% Other Institutional Investors
54.88% Public Companies and
Individual Investors